 | GLA | Name: | alpha-D-galactopyranose | Formula: | C6 H12 O6 | SMILES: | OC1C(O)C(OC(O)C1O)CO | InChi: | InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1 | Synonyms: | alpha-D-galactose | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | alpha-D-galactopyranose |
|
 | GLC | Name: | alpha-D-glucopyranose | Formula: | C6 H12 O6 | SMILES: | OC1C(O)C(OC(O)C1O)CO | InChi: | InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6+/m1/s1 | Synonyms: | alpha-D-glucose | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | alpha-D-glucopyranose |
|
 | GLJ | Name: | 5,5-dihydroxy-L-norvaline | Formula: | C5 H11 N O4 | SMILES: | O=C(O)C(N)CCC(O)O | InChi: | InChI=1S/C5H11NO4/c6-3(5(9)10)1-2-4(7)8/h3-4,7-8H,1-2,6H2,(H,9,10)/t3-/m0/s1 | Definition date: | 2011-02-09 | Last modified: | 2024-09-27 | Identifier: | 5,5-dihydroxy-L-norvaline |
|
 | GLK | Name: | (4S)-4-amino-5,5-dihydroxypentanoic acid | Formula: | C5 H11 N O4 | SMILES: | O=C(O)CCC(N)C(O)O | InChi: | InChI=1S/C5H11NO4/c6-3(5(9)10)1-2-4(7)8/h3,5,9-10H,1-2,6H2,(H,7,8)/t3-/m0/s1 | Definition date: | 2010-09-24 | Last modified: | 2024-09-27 | Identifier: | (4S)-4-amino-5,5-dihydroxypentanoic acid |
|
 | GLN | Name: | GLUTAMINE | Formula: | C5 H10 N2 O3 | SMILES: | O=C(N)CCC(N)C(=O)O | InChi: | InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | L-glutamine |
|
 | GLO | Name: | D-glucose | Formula: | C6 H12 O6 | SMILES: | O=CC(O)C(O)C(O)C(O)CO | InChi: | InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1 | Synonyms: | D-GLUCOSE IN LINEAR FORM | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | D-glucose |
|
 | GLU | Name: | GLUTAMIC ACID | Formula: | C5 H9 N O4 | SMILES: | O=C(O)C(N)CCC(=O)O | InChi: | InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | L-glutamic acid |
|
 | GLV | Name: | GLYOXYLIC ACID | Formula: | C2 H2 O3 | SMILES: | O=CC(=O)O | InChi: | InChI=1S/C2H2O3/c3-1-2(4)5/h1H,(H,4,5) | Synonyms: | GLYOXALATE | Definition date: | 1999-10-25 | Last modified: | 2024-09-27 | Identifier: | oxoacetic acid |
|
 | GLY | Name: | GLYCINE | Formula: | C2 H5 N O2 | SMILES: | O=C(O)CN | InChi: | InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | glycine |
|
 | GLZ | Name: | AMINO-ACETALDEHYDE | Formula: | C2 H5 N O | SMILES: | O=CCN | InChi: | InChI=1S/C2H5NO/c3-1-2-4/h2H,1,3H2 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | aminoacetaldehyde |
|
 | GM1 | Name: | AMINOMETHYLAMIDE | Formula: | C2 H6 N2 O | SMILES: | O=C(N)CN | InChi: | InChI=1S/C2H6N2O/c3-1-2(4)5/h1,3H2,(H2,4,5) | Synonyms: | GLYCINAMID | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | glycinamide |
|
 | GM8 | Name: | (2S)-2-[(1S,2S)-2-aminocyclohexyl]butanoic acid | Formula: | C10 H19 N O2 | SMILES: | O=C(O)C(CC)C1CCCCC1N | InChi: | InChI=1S/C10H19NO2/c1-2-7(10(12)13)8-5-3-4-6-9(8)11/h7-9H,2-6,11H2,1H3,(H,12,13)/t7-,8-,9-/m0/s1 | Definition date: | 2012-10-29 | Last modified: | 2024-09-27 | Release date: | 2013-06-12 | Identifier: | (2S)-2-[(1S,2S)-2-aminocyclohexyl]butanoic acid |
|
 | GMA | Name: | 4-AMIDO-4-CARBAMOYL-BUTYRIC ACID | Formula: | C5 H10 N2 O3 | SMILES: | O=C(N)C(N)CCC(=O)O | InChi: | InChI=1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)/t3-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | L-alpha-glutamine |
|
 | GME | Name: | 5-O-methyl-glutamic acid | Formula: | C6 H11 N O4 | SMILES: | O=C(OC)CCC(C(=O)O)N | InChi: | InChI=1S/C6H11NO4/c1-11-5(8)3-2-4(7)6(9)10/h4H,2-3,7H2,1H3,(H,9,10)/t4-/m0/s1 | Synonyms: | (2S)-2-amino-5-methoxy-5-oxopentanoic acid | Definition date: | 2009-10-09 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-5-methoxy-5-oxopentanoic acid (non-preferred name) |
|
 | GMO | Name: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-nitrophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C15 H16 N4 O6 | SMILES: | NC(C2=NC(=[C@H]c1ccc(cc1)[N+]([O-])=O)C(N2CC(O)=O)=O)C(O)C | InChi: | InChI=1S/C15H16N4O6/c1-8(20)13(16)14-17-11(15(23)18(14)7-12(21)22)6-9-2-4-10(5-3-9)19(24)25/h2-6,8,13,20H,7,16H2,1H3,(H,21,22)/b11-6-/t8-,13+/m1/s1 | Synonyms: | PEPTIDE DERIVED CHROMOPHORE | Definition date: | 2017-10-13 | Last modified: | 2024-09-27 | Release date: | 2018-10-17 | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-nitrophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | 8OV | Name: | N-(3-{[2-{[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]amino}phenyl)propanamide | Formula: | C27 H30 F3 N7 O3 | SMILES: | n1cc(c(nc1Nc2c(cc(cc2)N3CCN(C(=O)C)CC3)OC)Nc4cccc(c4)NC(CC)=O)C(F)(F)F | InChi: | InChI=1S/C27H30F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h5-9,14-16H,4,10-13H2,1-3H3,(H,32,39)(H2,31,33,34,35) | Definition date: | 2017-02-23 | Last modified: | 2024-09-27 | Release date: | 2017-10-18 | Identifier: | N-(3-{[2-{[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]amino}phenyl)propanamide |
|
 | 8PM | Name: | N~2~-{[7-(dimethylamino)-2,1,3-benzothiadiazol-4-yl]sulfonyl}-N-hexyl-N~2~-methylglycinamide | Formula: | C17 H27 N5 O3 S2 | SMILES: | c1(c2c(c(N(C)C)cc1)nsn2)S(=O)(N(C)CC(NCCCCCC)=O)=O | InChi: | InChI=1S/C17H27N5O3S2/c1-5-6-7-8-11-18-15(23)12-22(4)27(24,25)14-10-9-13(21(2)3)16-17(14)20-26-19-16/h9-10H,5-8,11-12H2,1-4H3,(H,18,23) | Definition date: | 2017-02-26 | Last modified: | 2024-09-27 | Release date: | 2017-03-08 | Identifier: | N~2~-{[7-(dimethylamino)-2,1,3-benzothiadiazol-4-yl]sulfonyl}-N-hexyl-N~2~-methylglycinamide |
|
 | 8PW | Name: | (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide | Formula: | C23 H25 F6 N3 O5 S | SMILES: | O=S(=O)(c1ccc(OCC(F)(F)F)cc1C(F)(F)F)C4CC(C(=O)NC2(C=[N@H])CC2)N(C(=O)C3(C)CC3)C4 | InChi: | InChI=1S/C23H25F6N3O5S/c1-20(4-5-20)19(34)32-10-14(9-16(32)18(33)31-21(11-30)6-7-21)38(35,36)17-3-2-13(37-12-22(24,25)26)8-15(17)23(27,28)29/h2-3,8,11,14,16,30H,4-7,9-10,12H2,1H3,(H,31,33)/b30-11+/t14-,16+/m1/s1 | Definition date: | 2013-06-03 | Last modified: | 2024-09-27 | Release date: | 2014-06-18 | Identifier: | (4R)-N-{1-[(E)-iminomethyl]cyclopropyl}-1-[(1-methylcyclopropyl)carbonyl]-4-{[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonyl}-L-prolinamide |
|
 | 8Q1 | Name: | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate | Formula: | C23 H45 N2 O8 P S | SMILES: | O=C(CCCCCCCCCCC)SCCNC(CCNC(C(C(COP(=O)(O)O)(C)C)O)=O)=O | InChi: | InChI=1S/C23H45N2O8PS/c1-4-5-6-7-8-9-10-11-12-13-20(27)35-17-16-24-19(26)14-15-25-22(29)21(28)23(2,3)18-33-34(30,31)32/h21,28H,4-18H2,1-3H3,(H,24,26)(H,25,29)(H2,30,31,32)/t21-/m0/s1 | Synonyms: | S-dodecanoyl-4'-phosphopantetheine | Definition date: | 2017-02-28 | Last modified: | 2024-09-27 | Release date: | 2017-06-21 | Identifier: | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate |
|
 | 8RC | Name: | 6-ethyl-3-[[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxy-pyrazin
e-2-carboxamide | Formula: | C30 H42 N8 O3 | SMILES: | CCc1nc(C(N)=O)c(Nc2ccc(cc2)N3CCC(CC3)N4CCN(C)CC4)nc1O[CH]5CCN(C5)C(=O)C=C | InChi: | InChI=1S/C30H42N8O3/c1-4-25-30(41-24-12-15-38(20-24)26(39)5-2)34-29(27(33-25)28(31)40)32-21-6-8-22(9-7-21)36-13-10-23(11-14-36)37-18-16-35(3)17-19-37/h5-9,23-24H,2,4,10-20H2,1,3H3,(H2,31,40)(H,32,34)/t24-/m1/s1 | Synonyms: | Naquotinib | Definition date: | 2017-08-31 | Last modified: | 2024-09-27 | Release date: | 2018-07-11 | Identifier: | 6-ethyl-3-[[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-5-[(3~{R})-1-prop-2-enoylpyrrolidin-3-yl]oxy-pyrazine-2-carboxamide |
|
 | 8RE | Name: | 3,4-dihydroxylysine | Formula: | C6 H14 N2 O4 | SMILES: | NCC[CH](O)[CH](O)[CH](N)C(O)=O | InChi: | InChI=1S/C6H14N2O4/c7-2-1-3(9)5(10)4(8)6(11)12/h3-5,9-10H,1-2,7-8H2,(H,11,12)/t3-,4-,5-/m0/s1 | Definition date: | 2017-02-28 | Last modified: | 2024-09-27 | Release date: | 2018-03-14 | Identifier: | (2~{S},3~{R},4~{S})-2,6-bis(azanyl)-3,4-bis(oxidanyl)hexanoic acid |
|
 | 8RQ | Name: | ~{N}4-[(4-chlorophenyl)methyl]-~{N}1-(cyclohexylmethyl)-~{N}4-cyclopentyl-~{N}1-[(~{Z})-4-[(~{E})-methyliminomethyl]-5-oxidanyl-hex-4-enyl]benzene-1,4-disulfonamide | Formula: | C33 H46 Cl N3 O5 S2 | SMILES: | CN=CC(CCCN(CC1CCCCC1)[S](=O)(=O)c2ccc(cc2)[S](=O)(=O)N(Cc3ccc(Cl)cc3)C4CCCC4)=C(C)O | InChi: | InChI=1S/C33H46ClN3O5S2/c1-26(38)29(23-35-2)11-8-22-36(24-27-9-4-3-5-10-27)43(39,40)32-18-20-33(21-19-32)44(41,42)37(31-12-6-7-13-31)25-28-14-16-30(34)17-15-28/h14-21,23,27,31,38H,3-13,22,24-25H2,1-2H3/b29-26-,35-23+ | Definition date: | 2017-02-28 | Last modified: | 2024-09-27 | Release date: | 2017-05-10 | Identifier: | ~{N}4-[(4-chlorophenyl)methyl]-~{N}1-(cyclohexylmethyl)-~{N}4-cyclopentyl-~{N}1-[(~{Z})-4-[(~{E})-methyliminomethyl]-5-oxidanyl-hex-4-enyl]benzene-1,4-disulfonamide |
|
 | 8RX | Name: | (3~{R})-3-(pent-4-ynylcarbamoyl)pyrrolidine-1-carboximidothioic acid | Formula: | C11 H17 N3 O S | SMILES: | SC(=N)N1CC[CH](C1)C(=O)NCCCC#C | InChi: | InChI=1S/C11H17N3OS/c1-2-3-4-6-13-10(15)9-5-7-14(8-9)11(12)16/h1,9H,3-8H2,(H2,12,16)(H,13,15)/t9-/m1/s1 | Definition date: | 2023-07-14 | Last modified: | 2024-09-27 | Release date: | 2024-01-31 | Identifier: | (3~{R})-3-(pent-4-ynylcarbamoyl)pyrrolidine-1-carboximidothioic acid |
|
 | 8SN | Name: | (3~{S},7~{R},10~{R},11~{R},13~{S})-11-methyl-2-oxidanylidene-1,4-diazatricyclo[8.3.0.0^{3,7}]tridec-8-ene-13-carboxylic acid | Formula: | C13 H18 N2 O3 | SMILES: | C[CH]1C[CH](N2[CH]1C=C[CH]3CCN[CH]3C2=O)C(O)=O | InChi: | InChI=1S/C13H18N2O3/c1-7-6-10(13(17)18)15-9(7)3-2-8-4-5-14-11(8)12(15)16/h2-3,7-11,14H,4-6H2,1H3,(H,17,18)/t7-,8+,9+,10+,11+/m1/s1 | Definition date: | 2017-03-03 | Last modified: | 2024-09-27 | Release date: | 2018-03-21 | Identifier: | (3~{S},7~{R},10~{R},11~{R},13~{S})-11-methyl-2-oxidanylidene-1,4-diazatricyclo[8.3.0.0^{3,7}]tridec-8-ene-13-carboxylic acid |
|
 | 8SU | Name: | (~{Z})-7-[(1~{R},5~{S})-2-oxidanylidene-5-[(~{E},3~{S})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]hept-5-enoic acid | Formula: | C20 H30 O4 | SMILES: | CCCCC[CH](O)C=C[CH]1C=CC(=O)[CH]1CC=CCCCC(O)=O | InChi: | InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1 | Synonyms: | PROSTAGLANDIN A2 (PGA2) | Definition date: | 2017-09-12 | Last modified: | 2024-09-27 | Release date: | 2019-03-27 | Identifier: | (~{Z})-7-[(1~{R},5~{S})-2-oxidanylidene-5-[(~{E},3~{S})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]hept-5-enoic acid |
|